Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Arcturus Therapeutics Holdings 164.57 Mn -46.81 Mn - 9.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.47 Mn
Dec 31, 2025 14.03 Mn
Sep 30, 2025 10.40 Mn
Jun 30, 2025 10.34 Mn
Mar 31, 2025 11.32 Mn
Dec 31, 2024 12.38 Mn
Sep 30, 2024 13.28 Mn
Jun 30, 2024 12.32 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 12.51 Mn
Sep 30, 2023 13.38 Mn
Jun 30, 2023 13.23 Mn
Mar 31, 2023 13.76 Mn
Dec 31, 2022 11.86 Mn
Sep 30, 2022 12.49 Mn
Jun 30, 2022 10.99 Mn
Mar 31, 2022 10.73 Mn
Dec 31, 2021 10.81 Mn
Sep 30, 2021 10.86 Mn
Jun 30, 2021 10.04 Mn